LGND - Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
IEX Last Trade
105.63
-0.230 -0.218%
Share volume: 113,893
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$105.86
-0.23
-0.22%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-28 | 2023-05-08 | 2023-08-09 | 2023-11-09 | 2024-02-29 | 2024-05-08 | |
| Cash flow financing | -59.442 M | -40.829 M | -5.298 M | -775.000 K | -67.757 M | 3.270 M | 5.315 M | 12.182 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 11.878 M | 20.489 M | 53.472 M | 33.948 M | -82.000 K | 7.646 M | 8.065 M | 18.732 M | |
| Net income | -895.000 K | 404.000 K | -17.485 M | 41.949 M | 2.290 M | -10.273 M | 18.188 M | 86.139 M | |
| Depreciation | 13.266 M | 13.478 M | 11.135 M | 9.499 M | 9.495 M | 8.611 M | 8.916 M | 8.765 M | |
| Changes in inventories | 24.773 M | 22.326 M | 13.294 M | 14.011 M | 26.906 M | 25.392 M | 23.969 M | 21.337 M | |
| Changes in receivables | 63.272 M | 65.953 M | 35.038 M | 29.188 M | 27.994 M | 36.003 M | 39.312 M | 28.435 M | |
| Investing Cashflow | 37.851 M | 19.176 M | -7.284 M | 10.549 M | 7.556 M | -19.503 M | -10.284 M | -3.775 M | |
| Net Borrowings | -40.715 M | -55.505 M | -138.529 M | -208.163 M | -221.811 M | -192.599 M | -174.141 M | -319.138 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -6.588 M | -4.329 M | -2.131 M | -2.414 M | -203.000 K | -487.000 K | -417.000 K | -2.548 M | |
| Cash Change | 147.935 M | 121.407 M | 211.870 M | 282.665 M | 219.041 M | 190.502 M | 170.309 M | 310.593 M |